DA
MRK icon

Dover Advisors’s Merck MRK Stock Holding History

Dover Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
12,880
+1,456
+13% +$170K 0.56% 51
2026
Q1 		$1.39M Sell
11,424
-1,456
-11% -$168K 0.57% 48
2025
Q4 		$1.37M Sell
12,880
-235
-2% -$22.1K 0.53% 53
2025
Q3 		$1.11M Sell
13,115
-162
-1% -$13.3K 0.44% 58
2025
Q2 		$1.05M Sell
13,277
-317
-2% -$25.2K 0.46% 56
2025
Q1 		$1.23M Buy
13,594
+603
+5% +$56.3K 0.54% 53
2024
Q4 		$1.29M Sell
12,991
-1,181
-8% -$122K 0.74% 43
2024
Q3 		$1.61M Buy
14,172
+1,838
+15% +$218K 0.91% 34
2024
Q2 		$1.53M Buy
12,334
+1,957
+19% +$252K 0.94% 31
2024
Q1 		$1.37M Buy
10,377
+4,208
+68% +$519K 0.94% 33
2023
Q4 		$677K Sell
6,169
-1,556
-20% -$162K 0.89% 39
2023
Q3 		$801K Buy
7,725
+205
+3% +$22.1K 0.81% 45
2023
Q2 		$873K Sell
7,520
-220
-3% -$25K 0.77% 43
2023
Q1 		$829K Buy
7,740
+1,213
+19% +$131K 0.8% 42
2022
Q4 		$729K Buy
+6,527
New +$667K 0.79% 43

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dover Advisors's MRK Position: Q2 2026 in Review

Dover Advisors increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $170K and bringing the position to 12,880 shares worth $1.37M. The position accounts for 0.56% of the portfolio, ranked #51.

Dover Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.61M in Q3 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dover Advisors held 12,880 shares of Merck worth $1.37M as of Q2 2026.
  • Dover Advisors bought 1,456 Merck shares in Q2 2026, an estimated $170K.
  • Merck made up 0.56% of Dover Advisors's portfolio in Q2 2026, its #51 holding.
  • Dover Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Dover Advisors's Merck position peaked at $1.61M in Q3 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dover Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.